Baxdrostat
A medication used in the treatment of hypertension
Baxdrostat | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Baxdrostat is a medication that acts as an inhibitor of the enzyme aldosterone synthase, which is involved in the production of the hormone aldosterone. It is primarily used in the treatment of hypertension, particularly in cases where patients have resistant hypertension that does not respond adequately to standard treatments.
Mechanism of Action[edit | edit source]
Baxdrostat works by selectively inhibiting the enzyme aldosterone synthase, also known as CYP11B2. This enzyme is responsible for the final step in the biosynthesis of aldosterone, a hormone that plays a crucial role in regulating blood pressure by controlling the balance of sodium and potassium in the body. By inhibiting aldosterone production, baxdrostat helps to lower blood pressure in patients with hypertension.
Clinical Use[edit | edit source]
Baxdrostat is indicated for use in patients with hypertension, particularly those with resistant forms of the condition. Resistant hypertension is defined as blood pressure that remains above target levels despite the use of three or more antihypertensive medications, including a diuretic.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of baxdrostat includes its absorption, distribution, metabolism, and excretion. After oral administration, baxdrostat is absorbed into the bloodstream and distributed throughout the body. It is metabolized primarily in the liver and excreted via the kidneys.
Side Effects[edit | edit source]
Common side effects of baxdrostat may include dizziness, fatigue, and hyperkalemia, which is an elevated level of potassium in the blood. Patients taking baxdrostat should be monitored for changes in electrolyte levels, particularly potassium.
Development and Approval[edit | edit source]
Baxdrostat was developed as part of ongoing efforts to find effective treatments for hypertension, especially in patients who do not respond to conventional therapies. It represents a novel approach by targeting the hormonal regulation of blood pressure.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD